From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|2|221-229

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.2, 2009-02, pp. : 221-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-02 ,pp. : 487-496

Spandidos Publications

Access to resources Recommend Favorite

C-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

By Gregory MacEwen E.   Kutzke Jon   Carew Jennifer   Pastor Josep   Schmidt Julie   Tsan Rachel   Thamm Douglas   Radinsky Robert  

Clinical and Experimental Metastasis, Vol. 20, Iss. 5, 2003-09 ,pp. : 421-430

Springer Publishing Company

Access to resources Recommend Favorite

Non-Receptor Tyrosine Kinase Inhibitors in Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 6, 2007-11 ,pp. : 633-642

Bentham Science Publishers

Access to resources Recommend Favorite

Ron-receptor tyrosine kinase in tumorigenesis and metastasis

By Leonis Mike A   Thobe Megan N   Waltz Susan E  

Future Oncology, Vol. 3, Iss. 4, 2007-08 ,pp. : 441-448

Future Medicine

Access to resources Recommend Favorite

Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials

By        

Molecular Medicine Reports, Vol. 8, Iss. 2, 2013-01 ,pp. : 655-661

Spandidos Publications

Access to resources Recommend Favorite